Louis M Weiner
Overview
Explore the profile of Louis M Weiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
6510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malchiodi Z, Suter R, Deshpande A, Peran I, Harris B, Duttargi A, et al.
bioRxiv
. 2024 Jun;
PMID: 38853982
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. PDAC's poor prognosis and resistance to immunotherapy are attributed in part to its dense, fibrotic tumor microenvironment...
2.
Libbey N, Gallagher L, Cantalino J, Weinberg B, Noel M, He A, et al.
J Gastrointest Cancer
. 2024 Feb;
55(2):852-861.
PMID: 38347342
Background: The role of neoadjuvant stereotactic body radiation therapy (SBRT) in the treatment of pancreatic adenocarcinoma (PDAC) is controversial and the optimal target volumes and dose-fractionation are unclear. The aim...
3.
Lekan A, Weiner L
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339310
Chemokines are small molecules that function as chemotactic factors which regulate the migration, infiltration, and accumulation of immune cells. Here, we comprehensively assess the structural and functional role of chemokines,...
4.
Zahavi D, Erbe R, Zhang Y, Guo T, Malchiodi Z, Maynard R, et al.
Cancer Biol Ther
. 2023 Oct;
24(1):2269637.
PMID: 37878417
Targeted monoclonal antibody therapy has emerged as a powerful therapeutic strategy for cancer. However, only a minority of patients have durable responses and the development of resistance remains a major...
5.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Cancer Res
. 2023 Sep;
83(21):3504-3506.
PMID: 37732910
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...
6.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Blood Cancer Discov
. 2023 Sep;
4(6):420-422.
PMID: 37732908
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...
7.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Clin Cancer Res
. 2023 Sep;
29(21):4338-4340.
PMID: 37732904
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...
8.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Cancer Prev Res (Phila)
. 2023 Sep;
16(11):591-594.
PMID: 37732897
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...
9.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Mol Cancer Res
. 2023 Sep;
21(11):1139-1141.
PMID: 37732893
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...
10.
Arteaga C, Cleveland J, Foti M, Mesa R, Weiner L, Willman C, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Sep;
32(11):1482-1484.
PMID: 37732892
Basic and clinical cancer research discoveries stemming from the nation's cancer centers have markedly improved outcomes for many cancer patients. Despite this forward momentum in our progress against this complex...